Is Abeona Therapeutics (ABEO) Inc a good buy right now?
Abeona Therapeutics Inc is a preliminary-stage biopharmaceutical organization, which takes part in the advancement of quality treatment for extreme and dangerous intriguing sicknesses. The firm operated in the healthcare sector. The market capitalization of ABEO is $36.73 million and has its headquarters in New York. The stock of Abeona Therapeutics trades under the symbol of […]
